by Elena Iemma | Feb 22, 2024 | Thinking Out Loud -Blog
In with the New! At this point in our evolution as a company, we can affirm that change is good! As promised, EpiVax 2.0 is emerging in 2024, with new products and new leaders! First, say hello to our new CEO, Rich-Henry Schabowsky, PhD JD. Rich-Henry is no stranger...
by Elena Iemma | Feb 22, 2024 | Thinking Out Loud -Blog
Immunogenicity assessment is key to drug safety. Currently there is no standard approach to the In Silico Immunogenicity Assessment of Therapeutic Peptides, however, the EpiVax team has worked with the FDA to develop several methods, including a validated in silico...
by Elena Iemma | Jan 30, 2024 | Featured, Thinking Out Loud -Blog
It’s Post-Pandemic and we’re back on the road traveling to the 4 corners of the Earth. Where will we get to see you? Here’s a list of upcoming events, and because … what’s travel without great food? … I’ve included some...
by Elena Iemma | Nov 27, 2023 | Featured, Thinking Out Loud -Blog
This is a two-way street Hey Hey, Hallo, Hola, Ciao, Namaste, Hello, Bonjour, Konnichiwa! When do you do your ‘thinking’ about the day? Do you do it while running? Well, I was thinking about you guys on my runs this week. I am finally back in Providence,...
by Elena Iemma | Nov 2, 2023 | Thinking Out Loud -Blog
See you in Munich… or Amsterdam! Before we get to the scary stuff, have you registered for the 9th annual Amsterdam Immunogenicity and Tolerance Seminar yet? We have an amazing line up of talks planned (see details here). A range of speakers from Cardiff and the...
by Elena Iemma | Sep 25, 2023 | Thinking Out Loud -Blog
Welcome to Tokyo! Yes! it’s true! – we’re in Tokyo! Sarah Moniz, Guilhem Richard (CTO of EpiVax Therapeutics) and I touched down on Friday and have been checking out Tokyo landmarks (aka lots of walking) over the weekend. We are beyond thrilled to...